This announcement is a separate document:
奥翔药业：奥翔药业关于非公开发行股票申请获得中国证监会核准批复的公告
Aoxiang Pharmaceutical: Aoxiang Pharmaceutical's announcement that its application for a non-public offering of shares has been approved and approved by the China Securities Regulatory Commission
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.